Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study

Diabetes/Metabolism Research and Reviews

Volumn 32, Issue 3, 2016, Pages 325-332

  Deng, Zixuan ^a   Gu, Yunjuan ^a,b   Hou, Xuhong ^a   Zhang, Lei ^a   Bao, Yuqian ^a   Hu, Cheng ^a   Jia, Weiping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b NANTONG UNIVERSITY   (China)

Author keywords

Cancer; Chinese population; Type 2 diabetes; Uric acid

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CHINESE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; URIC ACID BLOOD LEVEL; CHINA; COMPLICATION; HYPERURICEMIA; INCIDENCE; METABOLISM; MIDDLE AGED; MORTALITY; NEOPLASMS; PROGNOSIS; REGISTER; RISK FACTOR; SURVIVAL RATE; TRENDS;

AGED; CHINA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERURICEMIA; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROGNOSIS; REGISTRIES; RISK FACTORS; SURVIVAL RATE; URIC ACID;

EID: 84959481685     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2724     Document Type: Article

References (30)

1. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33(7): 1674-85. DOI: 10.2337/dc10-0666.
2. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterology hepatology Off Clin Prac J Am Gastroenterological Assoc 2006; 4(3): 369-80. DOI: 10.1016/j.cgh.2005.12.007.
3. Huxley R, Ansary-Moghaddam A. Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005; 92(11): 2076-83. DOI: 10.1038/sj.bjc.6602619.
4. Friberg E, Orsini N, Mantzoros CS, et al. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50(7): 1365-74. DOI: 10.1007/s00125-007-0681-5.
5. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97(22): 1679-87. DOI: 10.1093/jnci/dji375.
6. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer J Int du cancer 2007; 121(4): 856-62. DOI: 10.1002/ijc.22717.
7. Fang H, Yao B, Yan Y, et al. Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Diabetes Technol Ther 2013; 15(11): 914-22. DOI: 10.1089/dia.2013.0131.
8. Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. Jama 2008; 300(23): 2754-64. DOI: 10.1001/jama.2008.824.
9. Stein KB, Snyder CF, Barone BB, et al. Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 2010; 55(7): 1839-51. DOI: 10.1007/s10620-009-0944-8.
10. Peairs KS, Barone BB, Snyder CF, et al. Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol Off J Am Soc Clin Oncol 2011; 29(1): 40-6. DOI: 10.1200/JCO.2009.27.3011.
11. Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981; 78(11): 6858-62.
12. Kodama S, Saito K, Yachi Y, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care 2009; 32(9): 1737-42. DOI: 10.2337/dc09-0288.
13. Chuengsamarn S, Rattanamongkolgul S, Jirawatnotai S. Association between serum uric acid level and microalbuminuria to chronic vascular complications in Thai patients with type 2 diabetes. J Diabetes Complications 2014; 28(2): 124-9. DOI: 10.1016/j.jdiacomp.2013.12.002.
14. Xia J, Wang Z, Zhang F. Association between Related Purine Metabolites and Diabetic Retinopathy in Type 2 Diabetic Patients. Int J endocrinology 2014; 2014: 651050. DOI: 10.1155/2014/651050.
15. Li L, Yang C, Zhao Y, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol 2014; 15: 122. DOI: 10.1186/1471-2369-15-122.
16. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359(17): 1811-21. DOI: 10.1056/NEJMra0800885.
17. Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65(3): 1041-9. DOI: 10.1111/j.1523-1755.2004.00484.x.
18. Hammarsten J, Damber JE, Peeker R, et al. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer. Cancer Epidemiol 2010; 34(5): 574-9. DOI: 10.1016/j.canep.2010.06.014.
19. Szkandera J, Gerger A, Liegl-Atzwanger B, et al. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients. Clin Chem Lab Med CCLM / FESCC 2014. DOI: 10.1515/cclm-2014-0486.
20. Strasak AM, Rapp K, Hilbe W, et al. The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28 000 older Austrian women. Ann Oncol off J Eur Soc Med Oncol ESMO 2007; 18(11): 1893-7. DOI: 10.1093/annonc/mdm338.
21. Strasak AM, Rapp K, Hilbe W, et al. Serum uric acid and risk of cancer mortality in a large prospective male cohort. Cancer causes & control: CCC 2007; 18(9): 1021-9. DOI: 10.1007/s10552-007-9043-3.
22. Bo S, Cavallo-Perin P, Gentile L, et al. Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest 2001; 31(4): 318-21.
23. Nath SD, Voruganti VS, Arar NH, et al. Genome scan for determinants of serum uric acid variability. J Am Soc Nephrology: JASN 2007; 18(12): 3156-63. DOI: 10.1681/ASN.2007040426.
24. Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 2003; 425(6957): 516-21. DOI: 10.1038/nature01991.
25. Shi Y, Zheng W, Rock KL. Cell injury releases endogenous adjuvants that stimulate cytotoxic T cell responses. Proc Natl Acad Sci U S A 2000; 97(26): 14590-5. DOI: 10.1073/pnas.260497597.
26. Shin HS, Lee HR, Lee DC, et al. Uric acid as a prognostic factor for survival time: a prospective cohort study of terminally ill cancer patients. J Pain Symptom Manage 2006; 31(6): 493-501. DOI: 10.1016/j.jpainsymman.2005.11.014.
27. Cudmore RE, Boothroyd A. When are airgun pellets better left alone? Lancet 1985; 1(8431): 765-6.
28. Xu X, Rao GS, Groh V, et al. Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC Cancer 2011; 11: 194. DOI: 10.1186/1471-2407-11-194.
29. Fini MA, Elias A, Johnson RJ, et al. Contribution of uric acid to cancer risk, recurrence, and mortality. Clin translational med 2012; 1(1): 16. DOI: 10.1186/2001-1326-1-16.
30. Strasak AM, Lang S, Kneib T, et al. Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78, 850 men. Ann Epidemiol 2009; 19(1): 15-24. DOI: 10.1016/j.annepidem.2008.08.009.